Special report: Meet the 2026 Fierce 50
Biotech

A closer look at pharma's top R&D budgets

By Ayla Ellison, Darren Incorvaia, Gabrielle Masson Apr 4, 2025 9:34am
The Top Line research and development budget Merck & Co.

In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024. 

Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!

To learn more about the topics in this episode: 

To Listen to More Episodes of The Top Line

Check Out the Full List
The Top Line research and development budget Merck & Co. Johnson & Johnson Roche AstraZeneca AbbVie Bristol Myers Squibb Eli Lilly Pfizer Novartis Sanofi Biotech